Welcome! Login | Register
 

Worcester Teenagers Arrested for Carrying a Loaded Gun—Worcester Teenagers Arrested for Carrying a Loaded Gun

Man Arrested After Police Find Two Loaded Guns in his Worcester Apartment—Man Arrested After Police Find Two Loaded Guns…

Treasurer Goldberg Names Perez, Kim as Deputy Treasurers—Treasurer Goldberg Names Perez, Kim as Deputy Treasurers

Clutch Free Throws Lift Holy Cross Past Loyola 63-62—Clutch Free Throws Lift Holy Cross Past Loyola…

Central MA Senators to Host Commonwealth Conversations Tour 2017—Central MA Senators to Host Commonwealth Conversations Tour…

Holy Cross Football Names DiMichele Assistant Coach—Holy Cross Football Names DiMichele Assistant Coach

Two Teenagers Arrested Following Fight During North High School Basketball Game—Two Teenagers Arrested Following Fight During North High…

Man Shot After Walking Out of Apartment in Worcester—Man Shot After Walking Out of Apartment in…

Baker, State Leaders Release Report on Criminal Justice Reform in MA—Baker, State Leaders Release Report on Criminal Justice…

Worcester’s Greenwood to Speak on Faking Your Own Death at Clark—Worcester's Greenwood to Speak on Faking Your Own…

 
 

AG Announces $68.5 Million Settlement with AstraZeneca

Friday, March 11, 2011

 

Attorney General Peter Kilmartin announced today that a $68.5 million dollar settlement has been reached with AstraZeneca Pharmaceuticals.

This settlement, which is the largest ever multi-state consumer protection-based pharmaceutical settlement, is expected to bring $908,838 to the state.

The settlement stems from a complaint alleging that AstraZeneca used deceptive practices to market the antipsychotic drug Seroquel for off-label uses, according to the Attorney General. The company was accused of withholding information on the drug’s dangerous potential side effects, in addition to the negative results of scientific study done that tested the safety of the drug.

“This settlement shows the commitment of this office to protect consumers from deceptive marketing and advertising practices by big pharmaceutical companies,” Kilmartin said.

Company promises changes

AstraZeneca has promised to alter the way that it markets Seroquel, eliminating the misleading practices in question. Along with the $68.5 million payment, under the settlement AstraZeneca must comply with provisions addressing numerous concerns that an extensive 3-year investigation yielded. For example, AstraZeneca must have policies in place to ensure that sales personnel do not promote to health care providers who are unlikely to prescribe Seroquel for an FDA-approved use.

Other states participating in the investigation and settlement were: Florida, Illinois, Arizona, California, Colorado, Connecticut, Delaware, Hawaii, Idaho, Iowa, Kansas, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Missouri, Nebraska, Nevada, New Hampshire, New Jersey, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Dakota, Tennessee, Texas, Vermont, Washington, West Virginia and Wisconsin.
 

 

Enjoy this post? Share it with others.

 

X

Stay Connected — Free
Daily Email